Q3 2020 Johnson & Johnson Earnings Call Transcript
Good morning, and welcome to Johnson & Johnson's Third Quarter 2020 Earnings Conference Call. (Operator Instructions) This call is being recorded. (Operator Instructions)
I would now like to turn the conference call over to Johnson & Johnson. You may begin.
Good morning. This is Chris DelOrefice, Vice President of Investor Relations for Johnson & Johnson. Welcome to our company's review of business results for the third quarter of 2020. I hope everyone is healthy and continues to remain safe during these times.
Joining me on today's call is Joe Wolk, Executive Vice President and Chief Financial Officer. During the Q&A portion of the call, we're joined by Jennifer Taubert, Executive Vice President and Worldwide Chairman, Pharmaceuticals; Ashley McEvoy, Executive Vice President and Worldwide Chairman, Medical Devices; Thibaut Mongon, Executive Vice President and Worldwide Chairman, Consumer Health; and Mathai Mammen, Global Head of Janssen Research and Development.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |